reported that serum Gal-9 levels increased in patients with RA and were positively associated with RA disease activity in patients with low titers of anti-cyclic citrullinated peptide antibody (ACPA; <200 U/mL) (13). Here, PRTN3 is linked to rheumatoid arthritis.